RE: Directors bought1 Oct 2023 06:27
Stephen diggle a non executive director who has one of the largest investment funds across Asia invested over £5m of his own money in this project with his first buy at 168p over 3 years ago and has been averaging down ever since to around 14-20p this year, he mostly invests in bioscience projects and must have seen huge potential in OBD to have bought at the price he bought back then, there’s no doubt that at the time of his first buy he was looking at selling at multiples of that price, however these kind of investors usually wait for a buyout from a major pharma, I suspect this is the case here.